Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

Maureen P.M.H. Rutten-van Mölken, Elisabeth Sophia Hartgers-Gubbels*, Michael Chambers

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

2 Downloads (Pure)

Abstract

How is a cost-effectiveness analysis constructed and used? In this episode of the Value Insider podcast, host Mike Chambers speaks with Prof. Maureen Rutten-van Molken about economic evaluations in healthcare and how value is considered in these evaluations. Prof. Rutten-van Molken is professor of Economic Evaluation of Innovations for Health at the Erasmus University Rotterdam in the Netherlands. She leads the Erasmus HTA department and is Scientific Director of the Institute for Medical Technology Assessment (iMTA). Prof Rutten-van Molken explains how comparative assessments can help us understand which treatments offer the best value-for-money as reimbursement can only be allocated to a selection of all possible treatments.
Original languageEnglish
Pages (from-to)8055-8061
Number of pages7
JournalInternational Journal of General Medicine
Volume15
DOIs
Publication statusPublished - 9 Nov 2022

Bibliographical note

© 2022 Boehringer Ingelheim International GmbH.

Fingerprint

Dive into the research topics of 'Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]'. Together they form a unique fingerprint.

Cite this